CLRD Stock Overview
Clearday, Inc. operates as a non-acute longevity health care services company.
Clearday, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.93|
|52 Week High||US$5.45|
|52 Week Low||US$0.70|
|1 Month Change||-7.00%|
|3 Month Change||-19.83%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-73.96%|
Recent News & Updates
|CLRD||US Healthcare||US Market|
Return vs Industry: Insufficient data to determine how CLRD performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CLRD performed against the US Market.
|CLRD Average Weekly Movement||27.5%|
|Healthcare Industry Average Movement||8.6%|
|Market Average Movement||7.6%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: CLRD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 28% a week.
Volatility Over Time: CLRD's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Clearday, Inc. operates as a non-acute longevity health care services company. The company operates residential memory care communities in four U.S. states. It offers Clearday at Home, a digital service that connects the senior and their loved ones with proprietary programing that includes a range of activities, including physical and mental exercises; Clearday Network, a subscription service that helps agencies recruit and retain caregivers and enhance client experiences, as well as provides support and backbone to Clearday services; and Clearday Clubs, a membership-based adult day care model that provides daytime-only care primarily for individuals with Alzheimer’s disease, other dementias, or other lifestyle-limiting chronic health conditions.
Clearday, Inc. Fundamentals Summary
|CLRD fundamental statistics|
Is CLRD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CLRD income statement (TTM)|
|Cost of Revenue||US$22.52m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.54|
|Net Profit Margin||-227.54%|
How did CLRD perform over the long term?See historical performance and comparison